Abraxane: Melanoma Drug Helps Patients Live Longer In Trial
If approved, Abraxane would compete with products such as Bristol-Myers Squibb's Yervoy, known also as ipilimumab, and Roche
abraxane melanoma drug help patient live long trial approve abraxane compete product bristol myers squibb yervoy know ipilimumab roche